﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Genrated: Mon, 20 Apr 2026 08:40:34 GMT--><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:ev="http://purl.org/rss/1.0/modules/event/"><channel><title>Sarasota Hospital - Sarasota Memorial Health Care System</title><link>http://www.smh.com/Home/Services/Kolschowsky-Research-and-Education-Institute/Clinical-Trials/rss/1774</link><atom:link href="http://www.smh.com/Home/Services/Kolschowsky-Research-and-Education-Institute/Clinical-Trials/rss/1774" rel="self" type="application/rss+xml" /><description>RSS document</description><item><dc:creator><![CDATA[Casey Dean]]></dc:creator><title><![CDATA[Sarasota Memorial Joins International Study to Prevent Atrial Fibrillation After Heart Surgery]]></title><link>https://www.smh.com/Home/Services/Kolschowsky-Research-and-Education-Institute/Clinical-Trial/sarasota-memorial-joins-international-study-to-prevent-atrial-fibrillation-after-heart-surgery</link><description><![CDATA[ SARASOTA, Fla. (April 16, 2026) – New-onset atrial fibrillation (AFib) is one of the most common complications after heart surgery, affecting up to 50% of patients and often leading to longer ...]]></description><pubDate>Thu, 16 Apr 2026 17:09:00 GMT</pubDate><guid>https://www.smh.com/Home/Services/Kolschowsky-Research-and-Education-Institute/Clinical-Trial/sarasota-memorial-joins-international-study-to-prevent-atrial-fibrillation-after-heart-surgery</guid><dc:identifier><![CDATA[236db5cb-a9ed-4743-950c-af7a3f757e10-6604]]></dc:identifier></item><item><dc:creator><![CDATA[Casey Dean]]></dc:creator><title><![CDATA[Sarasota Memorial Enrolls First Patient in Novel Clinical Trial for the Treatment of Papillary Thyroid Cancer]]></title><link>https://www.smh.com/Home/Services/Kolschowsky-Research-and-Education-Institute/Clinical-Trial/sarasota-memorial-enrolls-first-patient-in-novel-clinical-trial-for-the-treatment-of-papillary-thyroid-cancer</link><description><![CDATA[ SARASOTA, Fla. (March 26, 2026) – Sarasota Memorial Health Care System (SMH) has enrolled the first patient in a clinical study evaluating the safety and effectiveness of a novel, minimally invasive ...]]></description><pubDate>Mon, 30 Mar 2026 15:24:00 GMT</pubDate><guid>https://www.smh.com/Home/Services/Kolschowsky-Research-and-Education-Institute/Clinical-Trial/sarasota-memorial-enrolls-first-patient-in-novel-clinical-trial-for-the-treatment-of-papillary-thyroid-cancer</guid><dc:identifier><![CDATA[236db5cb-a9ed-4743-950c-af7a3f757e10-6598]]></dc:identifier></item><item><dc:creator><![CDATA[Casey Dean]]></dc:creator><title><![CDATA[Sarasota Memorial Studies Novel Pacing Approach for Heart Failure Patients]]></title><link>https://www.smh.com/Home/Services/Kolschowsky-Research-and-Education-Institute/Clinical-Trial/sarasota-memorial-studies-novel-pacing-approach-for-heart-failure-patients</link><description><![CDATA[ SARASOTA, Fla. (March 11, 2026) – Cardiac resynchronization therapy with a defibrillator is a common treatment that uses an implanted device to help weakened or failing hearts beat more efficiently. ...]]></description><pubDate>Wed, 11 Mar 2026 18:56:00 GMT</pubDate><guid>https://www.smh.com/Home/Services/Kolschowsky-Research-and-Education-Institute/Clinical-Trial/sarasota-memorial-studies-novel-pacing-approach-for-heart-failure-patients</guid><dc:identifier><![CDATA[236db5cb-a9ed-4743-950c-af7a3f757e10-6574]]></dc:identifier></item><item><dc:creator><![CDATA[Casey Dean]]></dc:creator><title><![CDATA[SMH research study enrolling patients with advanced skin cancer]]></title><link>https://www.smh.com/Home/Services/Kolschowsky-Research-and-Education-Institute/Clinical-Trial/smh-research-study-enrolling-patients-with-advanced-skin-cancer</link><description><![CDATA[ SARASOTA, Fla. (Feb. 12, 2026) – Squamous cell carcinoma is one of the most common forms of skin cancer in the United States, affecting more than a million Americans each year. While most cases are ...]]></description><pubDate>Tue, 10 Mar 2026 19:27:00 GMT</pubDate><guid>https://www.smh.com/Home/Services/Kolschowsky-Research-and-Education-Institute/Clinical-Trial/smh-research-study-enrolling-patients-with-advanced-skin-cancer</guid><dc:identifier><![CDATA[236db5cb-a9ed-4743-950c-af7a3f757e10-6572]]></dc:identifier></item><item><dc:creator><![CDATA[Casey Dean]]></dc:creator><title><![CDATA[Sarasota Memorial Joins Clinical Trial for Patients with Aortic Valve Disease]]></title><link>https://www.smh.com/Home/Services/Kolschowsky-Research-and-Education-Institute/Clinical-Trial/sarasota-memorial-joins-clinical-trial-for-patients-with-aortic-valve-disease</link><description><![CDATA[ SARASOTA, Fla. (Jan. 8, 2026) – Calcification of the aortic valve is the leading cause of heart valve disease in older adults, and currently, there are no approved medications to slow its ...]]></description><pubDate>Thu, 08 Jan 2026 16:19:00 GMT</pubDate><guid>https://www.smh.com/Home/Services/Kolschowsky-Research-and-Education-Institute/Clinical-Trial/sarasota-memorial-joins-clinical-trial-for-patients-with-aortic-valve-disease</guid><dc:identifier><![CDATA[236db5cb-a9ed-4743-950c-af7a3f757e10-6494]]></dc:identifier></item><item><dc:creator><![CDATA[Casey Dean]]></dc:creator><title><![CDATA[New Clinical Trials at Sarasota Memorial Explore Gene Therapy Alternative to Bladder Removal Surgery]]></title><link>https://www.smh.com/Home/Services/Kolschowsky-Research-and-Education-Institute/Clinical-Trial/new-clinical-trials-at-sarasota-memorial-explore-gene-therapy-alternative-to-bladder-removal-surgery</link><description><![CDATA[ Sarasota Memorial’s Kolschowsky Research and Education Institute is participating in two clinical trials looking at potential non-surgical options for patients with early-stage bladder cancer, known ...]]></description><pubDate>Wed, 17 Dec 2025 17:44:00 GMT</pubDate><guid>https://www.smh.com/Home/Services/Kolschowsky-Research-and-Education-Institute/Clinical-Trial/new-clinical-trials-at-sarasota-memorial-explore-gene-therapy-alternative-to-bladder-removal-surgery</guid><dc:identifier><![CDATA[236db5cb-a9ed-4743-950c-af7a3f757e10-6470]]></dc:identifier></item><item><dc:creator><![CDATA[Casey Dean]]></dc:creator><title><![CDATA[Now Enrolling Patients in Clinical Trial for Innovative AFib Treatment]]></title><link>https://www.smh.com/Home/Services/Kolschowsky-Research-and-Education-Institute/Clinical-Trial/now-enrolling-patients-in-clinical-trial-for-innovative-afib-treatment</link><description><![CDATA[ Atrial fibrillation (AFib), is the most common treated heart arrhythmia, affecting over 6 million American adults.  Sarasota Memorial’s Kolschowsky Research and Education Institute  is participating ...]]></description><pubDate>Fri, 24 Oct 2025 18:19:00 GMT</pubDate><guid>https://www.smh.com/Home/Services/Kolschowsky-Research-and-Education-Institute/Clinical-Trial/now-enrolling-patients-in-clinical-trial-for-innovative-afib-treatment</guid><dc:identifier><![CDATA[236db5cb-a9ed-4743-950c-af7a3f757e10-6361]]></dc:identifier></item><item><dc:creator><![CDATA[Casey Dean]]></dc:creator><title><![CDATA[Research Study Testing aXess™ Dialysis Conduit]]></title><link>https://www.smh.com/Home/Services/Kolschowsky-Research-and-Education-Institute/Clinical-Trial/research-study-testing-axess-dialysis-conduit</link><description><![CDATA[ People living with end-stage kidney disease require safe and dependable hemodialysis access. Common complications with existing dialysis access include infections, blood clots, and stenosis ...]]></description><pubDate>Mon, 20 Oct 2025 15:30:00 GMT</pubDate><guid>https://www.smh.com/Home/Services/Kolschowsky-Research-and-Education-Institute/Clinical-Trial/research-study-testing-axess-dialysis-conduit</guid><dc:identifier><![CDATA[236db5cb-a9ed-4743-950c-af7a3f757e10-6348]]></dc:identifier></item><item><dc:creator><![CDATA[Casey Dean]]></dc:creator><title><![CDATA[Clinical Trial for Patients with Hard-to-Treat Ovarian Cancer]]></title><link>https://www.smh.com/Home/Services/Kolschowsky-Research-and-Education-Institute/Clinical-Trial/clinical-trial-for-patients-with-hard-to-treat-ovarian-cancer</link><description><![CDATA[ Women with advanced or recurring ovarian, peritoneal, or fallopian tube cancer may be eligible to participate in a new clinical trial offered by  Sarasota Memorial’s Kolschowsky Research   and   ...]]></description><pubDate>Thu, 02 Oct 2025 13:56:00 GMT</pubDate><guid>https://www.smh.com/Home/Services/Kolschowsky-Research-and-Education-Institute/Clinical-Trial/clinical-trial-for-patients-with-hard-to-treat-ovarian-cancer</guid><dc:identifier><![CDATA[236db5cb-a9ed-4743-950c-af7a3f757e10-6338]]></dc:identifier></item><item><dc:creator><![CDATA[Casey Dean]]></dc:creator><title><![CDATA[Multi-Center Trial of New Drug Targeting Resistant, Late-Stage Ovarian Cancer]]></title><link>https://www.smh.com/Home/Services/Kolschowsky-Research-and-Education-Institute/Clinical-Trial/multi-center-trial-of-new-drug-targeting-resistant-late-stage-ovarian-cancer</link><description><![CDATA[ While ovarian cancer is relatively rare, it is a stealthy disease, with no noticeable symptoms until it reaches an advanced, less treatable stage.  

 Standard treatment in these later stages ...]]></description><pubDate>Thu, 02 Oct 2025 13:49:00 GMT</pubDate><guid>https://www.smh.com/Home/Services/Kolschowsky-Research-and-Education-Institute/Clinical-Trial/multi-center-trial-of-new-drug-targeting-resistant-late-stage-ovarian-cancer</guid><dc:identifier><![CDATA[236db5cb-a9ed-4743-950c-af7a3f757e10-6337]]></dc:identifier></item></channel></rss>